Subject: Re: Drug costs $25. Sells for $25k.
The company said external price estimates were based on assumptions of higher use of HIV prevention drugs than currently, or projected. It said global price planning was in progress and would take into account “nearly two decades of research and development, constant learning and iteration, and manufacturing investments to deliver lenacapavir at scale”.

While it's tempting to say "give it away", I wounder if you do a current-value, not only of the 20 year's worth of work on this drug, but also the prorated costs of dry runs which failed, how you would amortize the costs into the price.

Jeff